DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n
Showing posts with label Merck. Show all posts
Showing posts with label Merck. Show all posts

Sunday, 25 December 2016

Reflections on Chirality in the Pharmaceutical Industry: Past, Present and Future Dr. Christopher J. Welch, Distinguished Scientist Process Research & Development Merck Research Laboratories, USA


Image result for Christopher J. Welch
New Technologies, Postdoc Program, Science Lead, Analytical Chemistry at Merck
Reflections on Chirality in the Pharmaceutical Industry: Past, Present and Future Dr. Christopher J. Welch, Distinguished Scientist Process Research & Development Merck Research Laboratories, USA   





A PRESENTATION
Image result for WAIT FOR PRESENTATION TO LOAD ANIMATION
   

Image result for loading gif


At Chiral India 2016, New horizons in Drug development, Harnessing the power of Chirality .Organised by chemical weekly at Holiday inn international, Mumbai, India, Nov 8 2016



Christopher J. Welch

Science Lead for Analytical Chemistry
Merck Research Laboratories
Christopher J. Welch is Science Lead for Analytical Chemistry within the Process and Analytical Chemistry area at Merck Research Laboratories in Rahway, NJ.  Chris leads the New Technologies Review and Licensing Committee (NT-RLC), the organization that oversees identification, acquisition and evaluation of new technologies of potential value to Merck Research Laboratories.  Chris also leads the MRL Postdoctoral Research Fellows Program.  He received his BS degrees in Chemistry and Biochemistry from the University of Illinois at Urbana-Champaign in 1982 and a Ph.D. degree in Organic Chemistry (also U of I) in 1992. Dr. Welch has worked in a variety of fields within the chemical industry, including discovery synthesis of agrochemicals (Velsicol-Sandoz), development of reagents for improved immunodiagnostic assays (Abbott Laboratories), and development and commercialization of chromatographic stationary phases, reagents and enantioselective catalysts within a small chemical business environment (Regis Technologies).  Since joining Merck in 1999, he has focused on developing and applying improved methods and equipment for purification, synthesis and analysis of pharmaceuticals and intermediates.  Dr. Welch has authored more than 230 scientific publications and patents.  He is co-founder of the journal, Enantiomer, a current or past member of the editorial advisory boards for the journals, Chirality, Organic & Biomolecular ChemistryJournal of the Korean Chemical SocietyChemistry WorldChemical & Engineering News and ACS Central Science.  Chris is past chair of the ACS Division of Organic Chemistry (ORGN), a member of the Executive Committee for the International Symposia on Chirality, a member of the ACS steering committee for Pacifichem and a member of the PittCon Program Resource Team.  Honors and awards include the NJCG Award for Excellence in Chromatography (2004), the PACS Activated Carbon Hall of Fame award (2007), MRL Presidents Award for Environmental Achievement (2009), Microsoft Life Science Innovation Award (2010), Fellow of the American Chemical Society (2010), Fellow of the American Association for the Advancement of Science, AAAS (2013), the Chirality Medal (2015) and the University of Nebraska Industrial Advisory Board Award (2016).

Experience




Distinguished Scientist, Process & Analytical Chemistry

Merck & Co., Inc.
– Present (17 years 8 months)Rahway, NJ
Current responsibilities: Scientific Lead, Analytical Chemistry co-chair, New Technologies Review & Licensing Committee (NT-RLC) co-chair, Merck Research Laboratories Postdoctoral Research Fellows Committee
Previous Positions at Merck: Science Lead, Global Analytical Chemistry 8/10 – 8/12 Distinguished Senior Investigator, Process Research 7/07 – 8/10 Associate Director. Process Research 1/06 – 6/07 Senior Research Fellow, Process Research 6/03 – 12/05 Research Fellow, Process Research 5/99 – 6/03

Director of Research

Regis Technologies
(6 years 11 months)Morton Grove, IL (Chicago area)
- New product development and commercialization (chromatography columns, reagents, enantioselective catalysts) - Scientific evaluation of custom organic synthesis business - Set up contract synthesis/preparative chromatographic separation business - first of kind

Honors & Awards

Fellow

American Association for the Advancement of Science (AAAS)

Fellow

American Chemical Society (ACS)

Chirality Medal 2015

Presidential Green Chemistry Award

US Environmental Protection Agency

– for precompetitive collaboration between Merck, Pfizer, Eli Lilly and University of Wisconsin on Aerobic Oxidation Methods for Pharmaceutical Synthesis - co-awardees: Shannon Stahl and Thatcher Root (U. Wisconsin), Joel Hawkins (Pfizer) and Joe Martinelli (Lilly)

Industrial Advisory Board (IAB) Award

University of Nebraska Department of Chemistry

Inaugural IAB award from U. Nebraska recognizing excellence in scientific research in an industry setting

Christopher J Welch

Organizations



American Chemical Society, Division of Organic Chemistry (ORGN)

Councilor and Chair

Pacifichem

Member of Steering Committee for Pacifichem 2020
Starting



Chirality (Journal)

member, editorial board
Starting

Chemical & Engineering News

member, editorial advisory board
Starting

Chemistry Today (RSC)

member, editorial advisory board
Starting



Journal of the Korean Chemical Society

member, international advisory board
Starting

Pittcon

Member, Pittcon Program Committee Resource Team
Starting

ACS Central Science

Member of Editorial Advisory Board
Starting



American Chemical Society

Member, Committee on Science (ComSci
Starting

Image result for Christopher Welch MERCK

Publications

2014 publications, part 1

Use of a Miniature Mass Spectrometer to Support Pharmaceutical Process Research Investigations, Org. Proc. R&D 18, 103-108, 2014.
Chromatographic Separation and Assignment of Absolute Configuration of Hydroxywarfarin Isomers, Chirality 26, 95-101, 2014. Chromatographic Resolution of Closely Related Species in Pharmaceutical Chemistry: Dehalogenation Impurities and Mixtures of Halogen...more



2014 publications - part 2


Precompetitive Collaboration on Enabling Technologies for the Pharmaceutical Industry, Org. Proc. R&D 18, 481–487, 2014.
Imine-based Chiroptical Sensing Approach for Analysis of Chiral Amines: From Method Design to Synthetic Application, Chem. Sci. 5, 2855-2861, 2014. Advances in Achiral Stationary Phases for SFC, Amer. Pharm. Rev., April 2014, 36-41. Liquid Chromatography Methods for...more

2013 Publications

Evaluation of core–shell particle columns for ion-pair reversed-phase liquid chromatography analysis of oligonucleotides, J. Pharm. Biomed. Anal. 72, 25–32, 2013.
Pharmaceutical Industry Practices on Genotoxic Impurities, in Pharmaceutical Industry Practices on Genotoxic Impurities, ed Heewoon Lee, Taylor & Francis, 2013. Rapid Analysis of Residual Palladium in Pharmaceutical...more

2012 Publications
2012
A Simple Parallel Gas Chromatography Column Screening System, Wes Schafer, Simon E. Hamilton, Zainab Pirzada and Christopher J. Welch, Chirality, 24,1–4, 2012.
Rapid catalyst identification for the synthesis of the pyrimidinone core of HIV integrase inhibitors, A. Bellomo, N. Celebi-Olcum, X. Bu, N. Rivera, R.T. Ruck, C.J. Welch, K.N. Houk, S.D. Dreher, Angew. Chem. Int. Ed., 51 (2012) 1-5 ...more

2011 Publications

Application of Ion Mobility Spectrometry in Drug Substance Development, H. Gao, X. Jia, R. Xiang, X. Gong, C. Welch, Analytical Methods, 3, 1828-1837, 2011.
Analytical Method Volume Intensity Index:A Green Chemistry Metric for HPLC Methodology in the Pharmaceutical Industry, R. Hartman, R. Helmy, M. Al-Sayah, C. Welch, Green Chemistry 13, 934-939, 2011. Does an Axial Propeller Shape on a...more

2010 Publications

High-throughput metal screening in pharmaceutical samples by ICP-MS with automated flow injection using a modified HPLC configuration, Tu, Wang, Welch, J. Pharm. Biomed. Anal., 51, 90-95, 2010.
Systematic Evaluation of New Chiral Stationary Phases for Supercritical Fluid Chromatography Using a Standard Racemate Library, Pirzada, Personick, Biba, Gong, Zhou, Schafer, Welch, J. Chromaogr.A,...more

Adsorbent Screening for Metal Impurity Removal in Pharmaceutical Process(Link)

Organic Process Research & Development
February 23, 2005
A microtube screening approach affords simple and convenient assessment of the selective adsorption of metal impurities by a variety of different process adsorbents. This approach is helpful in identifying rapid solutions to metal impurity problems in pharmaceutical process research. Several examples illustrating the utility of the approach are presented.
Online Analysis of Flowing Streams Using Microflow HPLC

Journal of Pharmaceutical and Biomedical An
Response to Comment on “Cocktail Chromatography: Enabling the Migration of HPLC to Nonlaboratory Environments”(Link)

ACS Sustainable Chem. Eng. 2015, 3 (9), 1897.

ACS Sustainable Chem. Eng. 2015, 3 (9), 1897.
Education

University of Illinois at Urbana-Champaign
The University of Chicago





Image result for Christopher Welch MERCK
FUELING INNOVATION
Welch helped launch Merck's new postdoctoral research fellowship program.







/////////Reflections on Chirality in the Pharmaceutical Industry, Past, Present and Future Dr. Christopher J. Welch, Distinguished Scientist, Process Research & Development,  Merck Research Laboratories, USA, presentation

Monday, 2 May 2016

Seema Malhotra Manager - Global Regulatoy Affairs at Merck

Seema Malhotra

Seema Malhotra

Manager - Global Regulatoy Affairs at Merck


LINKS

Experience


Manager - Global Regulatoy Affairs

Merck Serono
 – Present (2 years 1 month)Frankfurt, Germany

Manager - Global Regulatoy Affairs

Merck Serono
 –  (1 year 11 months)Mumbai

Dy. Manager - Global Regulatory Affairs

Merck Serono
 –  (1 year 9 months)Mumbai Area, India

Education


Manipal College of Pharmaceutical Science

Master of Pharmacy, Pharmaceutics

Bombay College of Pharmacy

Bachelor of Pharmacy



///////

Tuesday, 12 January 2016

Chris Edlin, Director at Pharmaceutical Manufacturing Technology Centre

Chris Edlin.

Chris Edlin

Director at Pharmaceutical Manufacturing Technology Centre
  • Pharmaceutical Manufacturing Technology Centre
    University of Limerick,
    Castletroy,
    Limerick,
    Ireland
  • Telephone: +353 61 202293
  • Email: chris.edlin@ul.ie
Home

image

links



Summary

Experienced Research Director, fundraiser and CSO/CEO who has held leadership positions with Sanofi-Aventis, GSK, Roche, Medical Research Council Technology, iThemba Pharmaceuticals and PMTC.

Key Achievements:

• Grew start up from 3 to >25 FTEs
• Established and grew, from grass roots, an international chemistry CRO business with $MM turnover
• Delivered multiple clinical candidates across a variety of therapeutic areas
• Identified, built and funded multiple $MM international projects between Industry, Academia and PPPs

Strong communication, marketing, management and strategic thinking skills. Extensive and robust experience in forming networks and relationships and working across diverse cultures, levels and backgrounds.

Specialties: Production and delivery of business plans, Creating laboratory infrastructure, Hiring senior staff, Board level communication and facilitation, Team building, Innovation optimisation, Synthetic chemistry problem solving, Managing drug discovery and contract research projects, Project Management, Matrix leadership, Stake holder management, Strategy implementation, Neglected disease research, Technology assessment and delivery.



New appointment to lead on partnerships between medical research and industry

Chris Edlin joins as Head of Enterprise Research Partnerships for the College of Medicine, Biological Sciences & Psychology
New appointment to lead on partnerships between medical research and industry
Chris has joined the University of Leicester as Head of Enterprise Research Partnerships for The College of Medicine, Biological Sciences & Psychology, based in the Enterprise and Business Development Office.  He will primarily be responsible for developing new and expanding existing relationships between College research groups and industrial research partners and will take a leading role in assessing the industrial partnership potential of current research strengths across the College and accelerate the development of these enterprise opportunities.
Chris has previously held positions as Chief Scientific Officer at iThemba Pharmaceuticals (Johannesburg, South Africa), Group Leader (Medicinal Chemistry) with the Medical Research Council Technology, Team Leader (Medicinal Chemistry) with GSK and Roche Pharmaceuticals and Senior Medicinal Chemist with Sanofi Aventis.
Chris’s background in drug discovery has given him the opportunity to contribute to a broad range of activities from lead generation to the identification of clinical candidates across a number of different therapeutic areas including inflammation, respiratory diseases, HIV and infectious diseases working directly on multiple different target types (e.g. GPCRs, kinases and enzymes). Furthermore, he has considerable experience in managing drug discovery and contract research projects, matrix leadership, technology assessment and implementation, writing business plans, creating laboratory infrastructure, board level communication, intellectual property assessment and due diligence
He holds a first class degree in Chemistry and a PhD in Organic Chemistry, both awarded by the University of Durham, and is the author of over 40 scientific publications and patents.  He was elected as a Fellow of the Royal Society of Chemistry in 2012.\



Experience


Director

Pharmaceutical Manufacturing Technology Centre
 – Present (1 year 11 months)Limerick
Director of a new Centre in Pharmaceutical Manufacturing hosted at the University of Limerick (UL), with an ambitious research and development program. With seed funding from Enterprise Ireland, IDA and an industrial consortium of Irish and multinational companies the Centre will conduct innovative, high quality research in pharmaceutical manufacturing that has direct relevance to industry.

I am responsible for the overall direction, financial control (full P&L) and management of the research in the Centre. I am also responsible for delivering a five-year business plan with defined success metrics and research outcomes that are consistent with this business plan. Critical to the role is taking a leadership role in fostering pharmaceutical manufacturing research at a national and international level, in conjunction with industrial and academic partners, and funding agencies.
The Pharmaceutical Manufacturing Technology Centre (PMTC) is hosted by the University of Limerick with core funding of €1M per annum from the Irish government (Enterprise Ireland and the IDA Ireland). Income is supplemented with co-funding from industry and other public sources.
PMTC, established in December 2013, is led by an industry steering board with an active research program driven by its industry members. Companies access PMTC to create projects and execute world-beating industry-relevant research in advanced technology solutions to address contemporary manufacturing issues.




Head of Enterprise Research Partnerships

University of Leicester
 –  (1 year 2 months)Leicester, United Kingdom





Chief Scientific Officer
iThemba Pharmaceuticals
 –  (3 years 3 months)Johannesburg Area, South Africa
Responsible for project identification and funding in neglected diseases with a primary focus on TB discovery and HIV process innovation. Multiple international collaborative projects initiated and transitioned into H2L and LO. Most senior company officer with full P&L responsibility. Also responsible for fund raising, board and scientific advisory committee communication and company infrastructure and strategy.

Built and grew ($$MM turnover) a contract research division offering H2L and LO chemistry services from South Africa to a range of local and international clients



Director of Chemistry

iThemba Pharmaceuticals
 –  (1 year 4 months)Johannesburg Area, South Africa


Group Leader

MRCT
 –  (2 years 6 months)London, United Kingdom



Principal Scientist

GSK
 –  (4 years)Stevenage, United Kingdom




Team Leader

Roche
 –  (1 year)Welwyn Garden City, United Kingdom





Senior Medicinal Chemist

sanofi-aventis
 –  (2 years)London, United Kingdom

Education








University of Limerick

Master of Business Administration (M.B.A.)
 – 2017








Durham University

PhD, Chemistry








Durham University

BSc, Chemistry

First class honours
Awarded ICI scholarship for academic achievement

Honors & Awards

Fellow of the Royal Society of Chemistry

Royal Society of Chemistry

Associated Professor of Chemistry at the University of the Free State

University of the Free State

African Network for Drug Discovery and Diagnostic Innovation Centre of Excellence

World Health Organisation (via ANDI)

UL Hosts New €5M Pharmaceutical Manufacturing Technology Centre



Ul Hosts New €5m Pharmaceutical Manufacturing Technology Centre
The Minister for Skills, Research and Innovation, Damien English TD, recently launched the Pharmaceutical Manufacturing Technology Centre (PMTC) which will be headquartered at the University of Limerick. The State, through the Department of Jobs, Enterprise & Innovation, is investing €5M over the next 5 years in this industry-focussed Centre which will deliver advanced technology solutions to contemporary manufacturing issues currently challenging the Irish pharmaceutical sector. PMTC is the latest of 15 state-supported Technology Centres established jointly by Enterprise Ireland and IDA Ireland. The Centre brings together 24 industry partners and 9 Higher Education Institutes who will deliver the research.

The aim of PMTC is to make Ireland the global hub of pharmaceutical process innovation and manufacturing and ultimately support an industry which directly employs over 25,000 people. Manufacturing cost competitiveness and patent expiry are among the two most critical issues which threaten the future of this industry which contributes over €40BN in Irish exports per annum. The industry consortium currently comprises a mix of indigenous multinational pharmaceutical companies and SME’s including: Alkermes, Allergan Pharmaceutical, Applied Process Consulting, Astellas, Bristol-Myers Squibb Swords, Crest Solutions, Eli Lilly, Gilead, GSK, Helsinn Birex, Innopharma Labs, Janssen, Label Art, Leo Pharma, Merck Sharp Dohme, Pfizer, Process Analytics, Roche, Servier, Sigmoid Pharma, Takeda Pharmaceuticals, Techno-Path, Teva Pharmaceuticals and TopChem Pharma.
Pictured above are: Dr Chris Edlin, Director, PMTC, Minister Damien English, Dr Mary Shire, Vice President Research, UL, Professor Gavin Walker, Bernal Chair of Pharmaceutical Powder Engineering, UL and PMTC Research Team